MAPT and Alzheimer disease: We observed that GEE exposure significantly attenuated tau hyperphosphorylation at multiple AD-associated sites in the hippocampus, as measured by western blotting and immunohistochemical staining (Fig. 7a-c, Additional file 6: Figure S5).